Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Hims & Hers Health Inc. buy Guggenheim

Hims & Hers Health Inc.
Start price
€12.65
27.02.24 / 50%
Target price
€15.66
27.02.25
Performance (%)
208.38%
End price
€39.01
28.02.25
Summary
This prediction ended on 28.02.25 with a price of €39.01. The BUY prediction by Guggenheim for Hims & Hers Health Inc. saw massive gains of 208.38%. Guggenheim has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Hims & Hers Health Inc. -2.872% -2.872% -20.576%
iShares Core DAX® 0.170% 2.184% 15.013%
iShares Nasdaq 100 0.515% 0.370% 6.226%
iShares Nikkei 225® 1.614% 6.357% 21.242%
iShares S&P 500 -0.719% -0.275% 1.451%

Comments by Guggenheim for this prediction

In the thread Hims & Hers Health Inc. diskutieren
Prediction Buy
Perf. (%) 208.38%
Target price 15.662
Change
Ends at 27.02.25

Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Guggenheim from $15.00 to $17.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat

Guggenheim 
0
Report Share
27.02.24
In the thread Trading Hims & Hers Health Inc.
Prediction Buy
Perf. (%) 208.38%
Target price 15.662
Change
Ends at 27.02.25

Die von Guggenheim gewählte maximale Laufzeit wurde überschritten

Guggenheim 
0
Report Share
28.02.25

Stopped prediction by Guggenheim for Hims & Hers Health Inc.

buy
Hims & Hers Health Inc.

Start price
Target price
Perf. (%)
€11.00
28.02.23
€14.12
28.02.24
12.73%
29.02.24

Guggenheim 
28.02.23 50%